The South African Health Products Regulatory Authority has welcomed the US lifting of the suspension of the Johnson & Johnson vaccine.
The jab was suspended last week as a precautionary measure because of rare cases of blood clots.
SAHPRA says it will be monitoring developments.
Meanwhile, Health Minister Zweli Mkhize is expected to make an announcement on when the Sisonke trial will commence in South Africa.
More Stories
Malema Slams Zondo Appointment As Chief Justice
Struggle For Women Not Yet Over – Ramaphosa
Can The Future Of Technology Bridge The Gender Divide In Africa?
Soldiers Won’t Be Deployed Against The People Of SA – SANDF
The Impact Of Climate Change On Health And Healthcare
Gauteng DA Confident It Has The Numbers To Unseat Makhura
Long Overdue For A Female Premier In Province – KZN ANC
Tech Companies Making A Difference In Africa
Nomusa Dube-Ncube Tipped As KZN Premier
Cele Commends WC Police For Cocaine Bust
Blinken Compares South African Struggle For Equality To US
Cape Town Residents Urged To Use Water Sparingly